BAJAJ BROKING
The Nifty Pharma Index is made up of stocks belonging to 20 major pharma companies in the country, including Sun Pharmaceutical Industries, Cipla, Dr Reddy's Laboratories, Divi’s Laboratories, Lupin, Aurobindo Pharma, etc.
‘Nifty Pharma Index’ is a market index of the stocks belonging to several prominent pharmaceutical companies in India. This index captures the financial health of the Indian pharma giants in one number.
So, if you have just opened a demat account and want to track pharma stocks, you should start by tracking the Nifty Pharma Index.
This index is made up of 20 pharma companies listed on the National Stock Exchange of India (NSE). The values of the Nifty Pharma Index move up and down based on how the total free float market value of the pharma stocks in this index behave. Free float market value means the value of those shares, which can be traded publicly on stock exchanges.
In this manner, this index reflects how the biggest pharma companies in India are performing. If it moves up regularly, it shows that those companies must be performing well. Conversely, if it is on a downward trend for some time, it shows those companies might not be performing well. That said, at times, stock prices go up and down purely based on sentiment and not fundamentals.
The Nifty Pharma Index is made up of the stocks of the following pharma companies:
A careful analysis of the values of the Nifty Pharma Index can reveal interesting insights. Here are a few steps that you can follow for this analysis:
Keeping track of the Nifty Pharma Index can help you examine the health of the Indian pharma sector. Besides, you can use the steps mentioned above to analyse any sector. So, if you want to invest in the share market or Nifty, start by tracking various sectoral indices of Nifty.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Gold Rate Today | 15 January 2025 | Gold Price in India
15 Jan, 2025 | 40 Min. read
Delhi Court Discharges JSW Steel in Corruption Case; HC Clears Monnet Takeover
15 Jan, 2025 | 2 Min. read
IRFC Emerges L1 Bidder to Finance ₹3,167 Crore for Banhardih Coal Block
15 Jan, 2025 | 2 Min. read
Cipla’s Tax Demand Reduced to ₹559.18 Crores After Revision
15 Jan, 2025 | 2 Min. read
Govt Plans 5-6% Hike in Highway Budget for FY26 After FY25 Slump
15 Jan, 2025 | 2 Min. read
Rikhav Securities IPO- Key Objective & Deep Analysis
15 Jan, 2025 | 5 Min. read
HCL Tech expands partnership with Microsoft to transform contact centres
14 Jan, 2025 | 2 Min. read
BEL secures new orders worth Rs 561 crore, boosting FY25 order book
14 Jan, 2025 | 2 Min. read
ITI Ltd secures Rs 64 crore contracts for Wi-Fi and CCTV systems
14 Jan, 2025 | 2 Min. read
JSW Energy secures LoI for 3.6 GW KSK Mahanadi power plant
14 Jan, 2025 | 2 Min. read
Biocon Biologics’ Johor Bahru Facility Receives FDA VAI Classification
13 Jan, 2025 | 2 Min. read
Interarch Secures ₹221 Crore Projects in Semiconductors & Energy Storage
13 Jan, 2025 | 2 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading